1,2,3,6-Tetrahydropyridine
| Title | Journal |
|---|---|
| Highly selective indium mediated allylation of unprotected pentosylamines. | Organic letters 20120316 |
| Survival of Dopaminergic Amacrine Cells after Near-Infrared Light Treatment in MPTP-Treated Mice. | ISRN neurology 20120101 |
| Structure-activity relationship studies of sphingosine-1-phosphate receptor agonists with N-cinnamyl-β-alanine moiety. | Bioorganic & medicinal chemistry letters 20110301 |
| The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6. | Free radical research 20101101 |
| Complex I: inhibitors, inhibition and neurodegeneration. | Experimental neurology 20100801 |
| Molecular modeling study of 4-phenylpiperazine and 4-phenyl-1,2,3,6-tetrahydropyridine derivatives: a new step towards the design of high-affinity 5-HT1A ligands. | Bioorganic & medicinal chemistry letters 20100201 |
| S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond. | Cardiovascular psychiatry and neurology 20100101 |
| MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss. | Brain research 20080910 |
| 1,4-Bis(piperidin-1-ylcarbon-yl)benzene. | Acta crystallographica. Section E, Structure reports online 20080101 |
| Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. | Journal of molecular medicine (Berlin, Germany) 20071201 |
| Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras. | Journal of medicinal chemistry 20061214 |
| Physiological, biochemical, and genetic characterization of an alicyclic amine-degrading Mycobacterium sp. strain THO100 isolated from a morpholine-containing culture of activated sewage sludge. | Archives of microbiology 20061101 |
| Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060111 |
| Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. | Journal of molecular neuroscience : MN 20060101 |
| Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety. | Journal of neural transmission. Supplementum 20060101 |
| Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease. | Brain research. Molecular brain research 20050324 |
| Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23. | Pharmacology, biochemistry, and behavior 20050101 |
| Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders. | Journal of medicinal chemistry 20030925 |
| Influence of lipophilicity on the interactions of N-alkyl-4-phenyl-1,2,3,6-tetrahydropyridines and their positively charged N-alkyl-4-phenylpyridinium metabolites with cytochrome P450 2D6. | Drug metabolism and disposition: the biological fate of chemicals 20030501 |
| Bridging the gap between in vitro and in vivo toxicology testing. | Alternatives to laboratory animals : ATLA 20030101 |
| Design, synthesis, and biological characterization of bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective muscarinic agonists. | Journal of medicinal chemistry 20011220 |
| Rat liver microsomal enzyme catalyzed oxidation of 4-phenyl-trans-1-(2-phenylcyclopropyl)-1,2,3,6-tetrahydropyridine. | Bioorganic & medicinal chemistry 20010701 |
| Failure of GPI compounds to display neurotrophic activity in vitro and in vivo. | European journal of pharmacology 20010301 |